Fannie Mae, officially known as the Federal National Mortgage Association, has recently filed an updated disclosure under Rule 15Ga-1. This filing, submitted on November 10, 2026, is significant as it details the representations and warranties related to prime residential mortgages. Such updates are essential for maintaining transparency and compliance within the mortgage-backed securities market, which is integral to the financial system.
Fannie Mae operates as a federally-sponsored credit agency, playing a crucial role in the housing finance sector by providing liquidity and stability to the mortgage market. The company is classified under the Standard Industrial Classification (SIC) code 6111, which encompasses federal and federally-sponsored credit agencies. It is publicly traded on the OTC exchange under several ticker symbols, including FNMA, FNMFN, and FNMAO.
The recent filing, identified as ABS-15G/A, serves as an initial filing of representations and warranties disclosure. According to the filing, it states, "Initial Filing of Rule 15Ga-1 Representations and Warranties Disclosure." This update is part of Fannie Mae's ongoing commitment to regulatory compliance and investor transparency, especially in light of the Dodd-Frank Act's requirements.
This disclosure may affect various stakeholders, including investors, mortgage lenders, and other financial institutions involved in the mortgage-backed securities market. By providing detailed information about the assets backing their securities, Fannie Mae aims to enhance investor confidence and mitigate potential risks associated with mortgage defaults.
Looking ahead, the filing does not specify what actions will follow this update. However, it underscores Fannie Mae's proactive approach to regulatory compliance and its commitment to maintaining a transparent operating environment.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










